Biohaven Pharmaceutical Holding Company Ltd.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$9.7Mgeneral payments (2019-2025)
$176Kresearch payments (2019-2025)
52,988clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2022 $9.7M
2023 $9,275
2024 $0.00

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Neurology (Psychiatry & Neurology) $4.1M
Family Medicine $1.2M
Family $982K
Internal Medicine $629K
Physician Assistant $456K
Nurse Practitioner $367K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Eric Eross Phoenix, AZ Neurology (Psychiatry & Neurology) $142,441.73
Jaclyn Duvall Tulsa, OK Neurology (Psychiatry & Neurology) $105,939.48
Traci Purath Burlington, WI Neurology (Psychiatry & Neurology) $93,317.16
Steven Schnittman West Haven, CT Infectious Disease $89,750.00
Alan Rapoport Los Angeles, CA Neurology (Psychiatry & Neurology) $84,658.02
Andrew Blumenfeld Carlsbad, CA Neurology (Psychiatry & Neurology) $83,809.12
Pankaj Satija Houston, TX Neurology (Psychiatry & Neurology) $76,164.06
Shivang Joshi Westborough, MA Neurology (Psychiatry & Neurology) $73,875.52
Stephen Landy Tupelo, MS Neurology (Psychiatry & Neurology) $70,439.91
Franchesca Fiorito-Torres San Juan, PR Neurology (Psychiatry & Neurology) $61,980.49

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.